Whalegun
Lobbying

Ppla's latest lobbying report covers Q2 2026, at $31.2K. The four quarters Q4 2025–Q3 2026 total $93.8K. Its first report covers Q4 2022; the issues it reports most are Medical/Disease Research/Clinical Labs.

Ppla

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$93.8K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Ppla lobbying by quarter
Ppla lobbying by quarter
QuarterAmountReports
Q4 2022$18.7K1
Q1 2023$18.7K1
Q2 2023$18.7K1
Q3 2023$18.7K1
Q4 2023$18.7K1
Q1 2024$18.7K1
Q2 2024$18.8K1
Q3 2024$18.8K1
Q4 2024$18.8K1
Q1 2025$18.8K1
Q2 2025$18.8K1
Q3 2025$31.3K1
Q4 2025$31.3K1
Q1 2026$31.3K1
Q2 2026$31.3K1
Q3 2026$00

By issue

  • Medical research and clinical labs$331K · 15 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Food & Drug Administration (FDA)15 reports

Firms it paid

Firm
Richard J. Scholz, P.A.$331K15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
08/12for Q2Richard J. Scholz, P.A.$31.3K
04/15for Q1Richard J. Scholz, P.A.$31.3K
02/06for Q4 2025Richard J. Scholz, P.A.$31.3K
02/04for Q4 2025Richard J. Scholz, P.A.$31.3K
25/11/12for Q3 2025Richard J. Scholz, P.A.$31.3K
25/11/07for Q3 2025Richard J. Scholz, P.A.$31.3K
25/07/30for Q2 2025Richard J. Scholz, P.A.$18.8K
25/07/30for Q1 2025Richard J. Scholz, P.A.$18.8K
25/01/03for Q4 2024Richard J. Scholz, P.A.$18.8K
24/10/18for Q3 2024Richard J. Scholz, P.A.$18.8K
24/07/19for Q2 2024Richard J. Scholz, P.A.$18.8K
24/04/19for Q1 2024Richard J. Scholz, P.A.$18.7K
24/01/19for Q4 2023Richard J. Scholz, P.A.$18.7K
23/10/20for Q3 2023Richard J. Scholz, P.A.$18.7K
23/07/21for Q2 2023Richard J. Scholz, P.A.$18.7K
23/04/20for Q1 2023Richard J. Scholz, P.A.$18.7K
23/01/12for Q4 2022Richard J. Scholz, P.A.$18.7K